Lotte Chemical uses BASF stabilizer to provide high-definition medical polypropylene for COVID-19 vaccination syringes

Lotte Chemical, a major South Korean chemical company, has used BASF's Irgastab, a colorfast processing stabilizer, to produce PP for medical applications
.
According to a BASF press release, demand for syringes made from PP has grown exponentially as the Covid-19 vaccine is rolled out around the world
.

Lotte Chemical's medical PP has been applied to LDS (low dead space) syringes developed by a Korean medical syringe manufacturer
.
These specialized products are designed to minimize the amount of drug left in the tube after injection, thereby reducing vaccine waste
.
Therefore, LDS syringes are in huge global demand as it is estimated to enable more people to get doses with the same number of vaccines
.

Plastics used for medical purposes need to be sterilized
.
This can lead to polymer degradation and discoloration
.
“Irgastab helps ensure that medical PP remains safe and stable,” said Hermann Althoff, Senior Vice President Performance Chemicals Asia Pacific at BASF.
Syringes are critical because the material needs to be certified in high definition
.
”

As the demand for syringes for vaccination is expected to surge, Lotte Chemical is expanding the development of special PP materials to ensure strict control over the production quality of medical materials, including high-definition PP, and to accommodate growing demands related to healthcare and safety
.

Plastic syringes and many other medical applications help protect human health and safety, a key pillar of a sustainable future
.
Irgastab's sustainability benefits also extend to protecting the environment and valuable resources, shielding plastics at lower concentrations than other solutions in sensitive applications
.